Kingworld Medicines Group Limited (HKG:1110)

Market Cap	312.49M
Revenue (ttm)	1.03B
Net Income (ttm)	5.95M
Shares Out	589.60M
EPS (ttm)	0.01
PE Ratio	50.58
Forward PE	n/a
Dividend	0.03 (5.98%)
Ex-Dividend Date	Jun 5, 2025

Volume	4,184,000
Average Volume	1,616,718
Open	0.5500
Previous Close	0.5600
Day's Range	0.5200 - 0.5500
52-Week Range	0.3900 - 0.6400
Beta	0.80
RSI	33.12
Earnings Date	Aug 29, 2025

About Kingworld Medicines Group

Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series brands...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 972
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1110

Financial Performance

In 2024, Kingworld Medicines Group's revenue was 1.06 billion, a decrease of -1.63% compared to the previous year's 1.08 billion. Earnings were 41.56 million, an increase of 9.08%.

Financial numbers in CNY